Islet Management’s MedTech Acquisition Corporation Unit MTACU Stock Holding History
Bought
Maintained
Sold
Other funds holding MTACU
MP
GGHC
BCL
ZCA
MF
HF
TAL
Islet Management's MTACU Position: Q3 2021 in Review
Islet Management sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2021, closing a stake of 491,940 shares — an estimated $4.93M sold.
Islet Management first reported a position in MTACU in Q4 2020 and held it in 3 quarters. The position peaked at $5.25M in Q4 2020. 20 funds tracked by Wall St. Rank hold MTACU as of Q3 2021.
- Islet Management reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
- Islet Management sold 491,940 MedTech Acquisition Corporation Unit shares in Q3 2021, an estimated $4.93M.
- Islet Management first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
- Islet Management's MedTech Acquisition Corporation Unit position peaked at $5.25M in Q4 2020.
- 20 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2021.
Based on Islet Management's 13F filing for Q3 2021, filed 15 Nov 2021.